We are live on ! Find out more
ESGR

Enstar Group

Delisted

ESGR was delisted on the 1st of July, 2025.

122 hedge funds and large institutions have $1.1B invested in Enstar Group in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 40

4% more capital invested

Capital invested by funds: $1.06B → $1.1B (+$40.5M)

3% less funds holding

Funds holding: 126122 (-4)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
122
Holders Change
-4
Holders Change %
-3.17%
% of All Funds
3.53%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.03%
New
8
Increased
42
Reduced
40
Closed
11
Calls
Puts
Net Calls
Net Calls Change

ESGR Hedge Fund Activity: Q4 2013 in Review

122 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Enstar Group (ESGR) for Q4 2013, worth a combined $1.1B — up 3.8% from $1.06B a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ESGR and 8 opened new positions — a net loss of 3 holders — while 40 trimmed existing stakes and 42 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $11.5M. The largest seller was Advisory Research, cutting an estimated $5.58M.

  • 122 institutional investors held Enstar Group (ESGR) as of Q4 2013, down from 126 in Q3 2013.
  • Funds reported $1.1B of Enstar Group stock for Q4 2013, up 3.8% quarter-over-quarter.
  • 8 funds opened new Enstar Group positions in Q4 2013 and 11 closed out, a net change of -3 holders.
  • The largest Enstar Group buyer in Q4 2013 was T. Rowe Price Associates, an estimated $11.5M added.
  • The largest Enstar Group seller in Q4 2013 was Advisory Research, an estimated $5.58M sold.

Based on aggregated 13F filings for Q4 2013.